Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917

Nutrition Reviews

Volumn 68, Issue 8, 2010, Pages 459-464

  Trebichavsky, Ilja ^a   Splichal, Igor ^a   Rada, Vojtech ^b   Splichalova, Alla ^a,c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Escherichia coli Nissle 1917; Gut; Innate immunity

Indexed keywords

MUTAFLOR; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; ESCHERICHIA COLI; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE INFECTION; NONHUMAN; REVIEW; SEPTICEMIA; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INTESTINE MUCOSA; MUCOSAL IMMUNITY;

ESCHERICHIA COLI; ESCHERICHIA COLI NISSLE 1917; SUIDAE;

EPITHELIAL CELLS; ESCHERICHIA COLI; HUMANS; IMMUNITY, MUCOSAL; IMMUNOMODULATION; INTESTINAL MUCOSA; PROBIOTICS;

EID: 77956638584     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00305.x     Document Type: Review

References (50)

1. Coburn B, Grassl GA, Finlay BB. Salmonella, the host and disease: A brief review. Immunol Cell Biol. 2007;85:112-118.
2. Kankwatira AM, Mwafulirwa GA, Gordon MA. Non-typhoidal salmonella bacteraemia - an under-recognized feature of AIDS in African adults. Trop Doct. 2004;34:198-200.
3. Guarner F. Enteric flora in health and disease. Digestion. 2006;73(Suppl 1):5-12.
4. Senok AC, Ismaeel AY, Botta GA. Probiotics: Facts and myths. Clin Microbiol Infect. 2005;11:958-966.
5. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat Rev Microbiol. 2010; 8:171-184.
6. Dlabac V, Trebichavsky I, Rehakova Z, Hofmanova B, Splichal I, Cukrowska B. Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. Infect Immun. 1997;65:5238-5243.
7. Rothkotter HJ, Sowa E, Pabst R. The pig as a model of developmental immunology. Hum Exp Toxicol. 2002;21:533-536.
8. Vodicka P, Smetana K, Jr, Dvorankova B, et al. The miniature pig as an animal model in biomedical research. Ann NY Acad Sci. 2005;1049:161-171.
9. Pang X, Hua X, Yang Q, et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J. 2007;1:156-162.
10. Nissle A. Die antagonistische Behandlung chronischer Darmstoerunger mit Colibakterien. Med Klinik. 1918;2:29-30.
11. Schultz M. Escherichia coli. In: Versalovic J, Wilson M, eds. Therapeutic Microbiology: Probiotics and Related Strategies. Washington DC: ASM Press; 2008:83-96.
12. Grosse C, Scherer J, Koch D, Otto M, Taudte N, Grass G. A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol. 2006;62:120-131.
13. Valdebenito M, Crumbliss AL, Winkelmann G, Hantke K. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int J Med Microbiol. 2006;296:513-520.
14. Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K. The colicin G, H and X determinants encode microcinsMand H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology. 2003;149:2557-2570.
15. Grozdanov L, Zahringer U, Blum-Oehler G, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol. 2002;184:5912-5925.
16. Grozdanov L, Raasch C, Schulze J, et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol. 2004;186:5432-5441.
17. Lasaro MA, Salinger N, Zhang J, et al. F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl Environ Microbiol. 2009;75:246-251.
18. Barth S, Duncker S, Hempe J, Breves G, Baljer G, Bauerfeind R. Escherichia coli Nissle 1917 for probiotic use in piglets: Evidence for intestinal colonization. J Appl Microbiol. 2009;107:1697-1710.
19. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519.
20. Splichal I, Fagerhol MK, Trebichavsky I, Splichalova A, Schulze J. The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages. Immunobiology. 2005;209:681-687.
21. Kamada N, Inoue N, Hisamatsu T, et al. Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. Inflamm Bowel Dis. 2005;11:455-463.
22. Hudcovic T, Stepankova R, Kozakova H, Hrncir T, Tlaskalova-Hogenova H. Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficientmice. Folia Microbiol (Praha). 2007;52:618-626.
23. Ukena SN, Singh A, Dringenberg U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. Plos ONE. 2007;2:e1308.
24. Cukrowska B, Lodinova-Zadnikova R, Enders C, Sonnenborn U, Schulze J, Tlaskalova-Hogenova H. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol. 2002;55:204-209.
25. Pai R, Kang G. Microbes in the gut: A digestable account of host-symbiont interactions. Indian J Med Res. 2008;128:587-594.
26. Riley MA, Wertz JE. Bacteriocins: Evolution, ecology, and application. Annu Rev Microbiol. 2002;56:117-137.
27. Frana TS, Carlson SA, Rauser DC, Jones BD, Fergen BJ, Griffith RW. Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype Typhimurium in pigs. Am J Vet Res. 2004;65:1616-1620.
28. Reissbrodt R, Hammes WP, dal Bello F, et al. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett. 2009; 290:62-69.
29. Altenhoefer A, Oswald S, Sonnenborn U, et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol. 2004;40:223-229.
30. Mondel M, Schroeder BO, Zimmermann K, et al. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009;2:166-172.
31. Schulze J, Lorenz A, Mandel L. Colonisation of Escherichia coli in different gnotobiotic animal models. Microbial Ecol Health Dis. 1992;5:4-5.
32. Mandel L, Trebichavsky I, Splichal I, Schulze J. Stimulation of intestinal immune cells by E. coli in gnotobiotic piglets. In: Mestecky J, ed. Advances in Mucosal Immunology. New York: Plenum Press; 1995:463-464.
33. Trebichavsky I, Rada V, Splichalova A, Splichal I. Cross-talk of human gut with bifidobacteria. Nutr Rev. 2009;67:77-82.
34. Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol. 2009;131:40-51.
35. Miao EA, Andersen-Nissen E, Warren SE, Aderem A. TLR5 and Ipaf: Dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol. 2007;29:275-288.
36. Lammers KM, Helwig U, Swennen E, et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol. 2002;97:1182-1186.
37. Hafez M, Hayes K, Goldrick M, Grencis RK, Roberts IS. The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of TLR5, CD14, MyD88 and TRIF together with the induction of IL-8 expression via the MAPKpathway in epithelial cells. Infect Immun. 2010;78:2153-2162.
38. Wehkamp J, Harder J, Wehkamp K, et al. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infect Immun. 2004;72:5750-5758.
39. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun. 2007;75:2399-2407.
40. Striz I, Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245-253.
41. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun. 2001;69:3692-3696.
42. Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol. 1999;31:1307-1319.
43. Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R, Roberts IS. The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect Immun. 2009;77:2995-3003.
44. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram-negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29:117-124.
45. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, SchmidtMA.Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 2007;9:804-816.
46. Floch MH. Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr Treat Options Gastroenterol. 2003;6:283-288.
47. Henker J, Laass MW, Blokhin BM, et al. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr Infect Dis J. 2008;27:494-499.
48. Schroeder B, Duncker S, Barth S, et al. Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci. 2006;51:724-731.
49. von Buenau R, Jaekel L, Schubotz E, Schwarz S, Stroff T, Krueger M. Escherichia coli strain Nissle 1917: Significant reduction of neonatal calf diarrhea. J Dairy Sci. 2005;88:317-323.
50. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14:421-428.